Camrelizumab combined with microwave ablation and chemotherapy in the treatment of colorectal cancer with liver metastasis/pulmonary metastasis: a single-arm, prospective study

ABSTRACT: Interventions: Experimental group:Microwave ablation + camrelizumab + chemotherapy Primary outcome(s): 12-month progression-free survival Study Design: Single arm

DISEASE(S): Colorectal Cancer With Liver Metastasis/lung Metastasis

PROVIDER: 2716800 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR